Chicago Capital
TMO icon

Chicago Capital’s Thermo Fisher Scientific TMO Stock Holding History

Chicago Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.2M Buy
21,109
+467
+2% +$277K 0.33% 49
2026
Q2 		$10.3M Sell
20,642
-12,015
-37% -$5.77M 0.25% 59
2026
Q1 		$16.1M Sell
32,657
-3,037
-9% -$1.65M 0.43% 47
2025
Q4 		$20.7M Sell
35,694
-68
-0.2% -$38.5K 0.51% 48
2025
Q3 		$17.3M Sell
35,762
-1,774
-5% -$826K 0.43% 48
2025
Q2 		$15.2M Sell
37,536
-399
-1% -$167K 0.38% 53
2025
Q1 		$18.9M Sell
37,935
-1,634
-4% -$885K 0.53% 43
2024
Q4 		$20.6M Sell
39,569
-1,048
-3% -$576K 0.55% 44
2024
Q3 		$25.1M Buy
40,617
+1,878
+5% +$1.11M 0.7% 39
2024
Q2 		$21.4M Sell
38,739
-13,008
-25% -$7.45M 0.64% 43
2024
Q1 		$30.1M Buy
51,747
+23,718
+85% +$13.3M 0.92% 37
2023
Q4 		$14.9M Sell
28,029
-53,351
-66% -$25.8M 0.54% 43
2023
Q3 		$41.2M Sell
81,380
-4
-0% -$2.13K 1.93% 22
2023
Q2 		$42.5M Buy
81,384
+79,766
+4,930% +$43M 1.91% 24
2023
Q1 		$933K Buy
1,618
+12
+0.7% +$6.76K 0.05% 109
2022
Q4 		$884K Sell
1,606
-34
-2% -$18K 0.05% 112
2022
Q3 		$832K Buy
1,640
+6
+0.4% +$3.36K 0.05% 117
2022
Q2 		$888K Sell
1,634
-15
-0.9% -$8.26K 0.05% 119
2022
Q1 		$974K Sell
1,649
-224
-12% -$129K 0.04% 121
2021
Q4 		$1.25M Sell
1,873
-141
-7% -$88K 0.05% 113
2021
Q3 		$1.15M Buy
2,014
+116
+6% +$63.7K 0.04% 112
2021
Q2 		$957K Buy
1,898
+103
+6% +$48.6K 0.04% 115
2021
Q1 		$819K Buy
1,795
+252
+16% +$120K 0.03% 122
2020
Q4 		$719K Buy
1,543
+676
+78% +$317K 0.03% 133
2020
Q3 		$383K Buy
867
+84
+11% +$34.7K 0.02% 176
2020
Q2 		$284K Buy
+783
New +$262K 0.02% 188
2018
Q3 		– Sell
-2,042
Closed -$423K – 235
2018
Q2 		$423K Buy
+2,042
New +$433K 0.03% 163

Other funds holding TMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Chicago Capital's TMO Position: Q3 2026 in Review

Chicago Capital increased its Thermo Fisher Scientific (TMO) stake by 2.3% in Q3 2026, buying an estimated $277K and bringing the position to 21,109 shares worth $14.2M. The position accounts for 0.33% of the portfolio, ranked #49.

Chicago Capital first reported a position in TMO in Q2 2018 and has held it in 27 quarters since. The position peaked at $42.5M in Q2 2023. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Chicago Capital held 21,109 shares of Thermo Fisher Scientific worth $14.2M as of Q3 2026.
  • Chicago Capital bought 467 Thermo Fisher Scientific shares in Q3 2026, an estimated $277K.
  • Thermo Fisher Scientific made up 0.33% of Chicago Capital's portfolio in Q3 2026, its #49 holding.
  • Chicago Capital first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 27 quarters since.
  • Chicago Capital's Thermo Fisher Scientific position peaked at $42.5M in Q2 2023.
  • 1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Chicago Capital's 13F filing for Q3 2026, filed 13 Oct 2026.